CTX-439 |
CTX-439 : Inhibitor of CDK12, CDK13
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CDK12 |
|
|
| CDK13 |
|
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
The selectivity of CTX-439 within the CDK family was assessed using KdELECT assays at Eurofins Disco ...
Selectivity Assessment Description:
CTX-439 displayed exceptional selectivity over other CDKs, including CDK2 (Kd = 320 nM) and CDK9 (Kd ...
In Vitro Selectivity Assessment
Potency Assay Off-Target:
CTX-439 was tested against a panel of 468 kinases at a single concentration of 30 nM (KinomeScan; Eu ...
Selectivity Assessment Description:
Only 7 kinases, excluding CDK13, exhibited more than 65% inhibition. CDK12 was not included in the p ...
Potency Cellular
In Vitro
CDK12
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acsmedchemlett.6c00138
CDK13
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acsmedchemlett.6c00138
In Vivo Validations
Mouse
Dose: Mouse Cassette PK
Route of delivery:
Oral
Systemic clearance:
682 mL/h/kg
Area Under the Curve::
552.5 ng*h/mL
Bioavailability:
37%
DOI Reference: 10.1021/acsmedchemlett.6c00138
Chemical Information
| Molecular Formula | C30H32F3N9O4S |
| SMILEs | CCCC(=O)N(c1cnc(-c2cnc(OC)nc2)cn1)[C@H]1CC[C@@H](Nc2ncc(C(F)(F)F)c(-c3cncc(S(C)(=O)=O)c3)n2)CC1 |
| InChI | InChI=1S/C30H32F3N9O4S/c1-4-5-26(43)42(25-17-35-24(16-36-25)19-12-38-29(46-2)39-13-19)21-8-6-20(7-9-21)40-28-37-15-23(30(31,32)33)27(41-28)18-10-22(14-34-11-18)47(3,44)45/h10-17,20-21H,4-9H2,1-3H3,(H,37,40,41)/t20-,21+ |
| Molecular weight | 671.23 Da |
| AlogP | 4.7729000000000035 |
| HBond acceptors | 13 |
| HBond donors | 1 |
| Atoms | 79 |